KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) Stock Information | RedChip

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV)


$10.0500
+0.7250 ( +7.03% ) 189.7K

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

Market Data


Open


$10.0500

Previous close


$9.3250

Volume


189.7K

Market cap


N/A

Day range


$9.3150 - $10.0700

52 week range


$7.3900 - $16.8800

SEC Filings


Form Type Description Pages Date
8-k 8K-related 11 Oct 04, 2024
3 Insider transactions 2 Sep 11, 2024
4 Insider transactions 1 Sep 11, 2024
4 Insider transactions 1 Sep 10, 2024
8-k 8K-related 15 Sep 10, 2024
8-k 8K-related 12 Sep 05, 2024
10-q Quarterly Reports 46 Sep 05, 2024
4 Insider transactions 1 Aug 26, 2024
4 Insider transactions 1 Aug 26, 2024
def Proxies and info statements 4 Aug 22, 2024

Latest News